Purkinje cell survival in organotypic cultures: Implication of Rho and its downstream effector ROCK

Journal of Neuroscience Research

Volumn 86, Issue 3, 2008, Pages 531-536

  Julien, Sylvie ^a   Schnichels, Sven ^a   Teng, Henry ^b   Tassew, Nardos ^b   Henke Fahle, Sigrid ^a   Mueller, Bernhard K ^c   Monnier, Philippe P ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Cerebellum; Organotypic culture; Rho inhibition; ROCK inhibition

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; C2IN PROTEIN; CARRIER PROTEIN; EXOENZYME C3; GLIAL FIBRILLARY ACIDIC PROTEIN; H 1152; ISOLECTIN B4; PEP1 PEPTIDE; PEPTIDE; PROTEIN; RHO FACTOR; RHO KINASE; RHO KINASE INHIBITOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN SLICE; CELL COMPOSITION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; PURKINJE CELL; STAINING; TISSUE CULTURE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADP RIBOSE TRANSFERASES; AMIDES; ANIMALS; ANIMALS, NEWBORN; BOTULINUM TOXINS; CELL SURVIVAL; ENZYME INHIBITORS; GLIAL FIBRILLARY ACIDIC PROTEIN; LECTINS; MICE; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; PURKINJE CELLS; PYRIDINES; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; STAINING AND LABELING;

EID: 38849121551     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21511     Document Type: Article

References (19)

1. Barth H, Hofmann F, Olenik C, Just I, Aktories K. 1998. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin. Infect Immun 66:1364-1369.
2. Dubreuil CI, Winton MJ, McKerracher L. 2003. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol 162:233-243.
3. Dusart I, Airaksinen MS, Sotelo C. 1997. Purkinje cell survival and axonal regeneration are age dependent: an in vitro study. J Neurosci 17:3710-3726.
4. Ghoumari AM, Wehrle R, Bernard O, Sotelo C, Dusart I. 2000. Implication of Bcl-2 and caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur J Neurosci 12:2935-2949.
5. Ghoumari AM, Wehrle R, De Zeeuw CI, Sotelo C, Dusart I. 2002. Inhibition of protein kinase C prevents Purkinje cell death but does not affect axonal regeneration. J Neurosci 22:3531-3542.
6. Ikenoya M, Hidaka H, Hosoya T, Suzuki M, Yamamoto N, Sasaki Y. 2002. Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. J Neurochem 81:9-16.
7. Kim JS, Kim JG, Jeon CY, Won HY, Moon MY, Seo JY, Kim JI, Kim J, Lee JY, Choi SY, Park J, Park JHY, Ha KS, Kim PH, Park JB. 2005. Downstream components of RhoA required for signal pathway of superoxide formation during phagocytosis of serum opsonized zymosans in macrophages. Exp Mol Med 37:575-587.
8. Kobayashi K, Takahashi M, Matsushita N, Miyazaki JI, Koike M, Yaginuma H, Osumi N, Kaibuchi K, Kobayashi K. 2004. Survival of developing motor neurons mediated by Rho GTPase signaling pathway through Rho-kinase. J Neurosci 24:3480-3488.
9. Lehmann M, Fournier A, Selles-Navarro I, Dergham P, Sebok A, Leclerc N, Tigyi G, McKerracher L. 1999. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 19:7537-7547.
10. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431.
11. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. 2004. Microglia promote the death of developing Purkinje cells. Neuron 41:535-547.
12. Monnier PP, Sierra A, Schwab JM, Henke-Fahle S, Mueller BK. 2003. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 22:319-330.
13. Morris MC, Depollier J, Mery J, Heitz F, Davita G. 2001. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19:1173-1176.
14. Sasaki Y, Suzuki M, Hidaka H. 2002. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther 93:225-232.
15. Schwab JM, Hirsch S, Monnier PP, Brechtel K, Tura A, Adibzadeh M, Stiefel A, Leppert C, Barth H, Aktories K, Mueller BK. 2002. The Rho-GTPase inhibitor C2IN-C3 induces functional neuronal recovery in a rat model of severe spinal cord injury.Neurosciences Meeting, Orlando, Florida.
16. Stoppini L, Buchs PA, Mueller D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
17. Svoboda KK, Moessner P, Field T, Acevedo J. 2004. ROCK inhibitor (Y27632) increases apoptosis and disrupts the actin cortical mat in embryonic avian corneal epithelium. Dev Dyn 229:579-590.
18. Winton MJ, Dubreuil CI, Lasko D, Leclerc N, McKerracher L. 2002. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J Biol Chem 277:32820-32829.
19. Xia H, Mao Q, Davidson BL. 2001. The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat Biotechnol 19:640-644.